- Investing Ideas
- /
- Software Healthcare Sector
Software Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Nutex Health
Market Cap: US$667.4m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$120.73
7D
5.3%
1Y
1,813.6%
IRADIMED
Market Cap: US$659.4m
Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.
IRMD
US$51.86
7D
-3.0%
1Y
19.0%
Day One Biopharmaceuticals
Market Cap: US$653.8m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$6.45
7D
-18.7%
1Y
-59.7%
Immunome
Market Cap: US$649.1m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$7.46
7D
-12.2%
1Y
-52.2%
PolyNovo
Market Cap: AU$1.0b
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
PNV
AU$1.47
7D
14.5%
1Y
-34.6%
GH Research
Market Cap: US$643.9m
Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.
GHRS
US$10.38
7D
-8.9%
1Y
-19.0%
Evolus
Market Cap: US$631.9m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$9.80
7D
-18.9%
1Y
-23.1%
Dianthus Therapeutics
Market Cap: US$629.3m
A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.
DNTH
US$19.59
7D
-9.7%
1Y
-19.3%
Curaleaf Holdings
Market Cap: CA$863.4m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.14
7D
-11.6%
1Y
-85.1%
Arbutus Biopharma
Market Cap: US$618.5m
A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.
ABUS
US$3.23
7D
-10.0%
1Y
12.2%
Integral Diagnostics
Market Cap: AU$952.9m
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.56
7D
7.1%
1Y
3.6%
AbCellera Biologics
Market Cap: US$604.9m
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$2.03
7D
-7.3%
1Y
-47.3%
Beta Bionics
Market Cap: US$604.8m
A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.
BBNX
US$13.95
7D
17.9%
1Y
n/a
Simulations Plus
Market Cap: US$603.7m
Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
SLP
US$30.02
7D
-10.7%
1Y
-38.8%
Savara
Market Cap: US$602.3m
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$2.86
7D
-15.9%
1Y
-38.6%
Fulgent Genetics
Market Cap: US$599.7m
Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
FLGT
US$19.70
7D
0.7%
1Y
-11.2%
Replimune Group
Market Cap: US$593.8m
A clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.
REPL
US$7.71
7D
-23.0%
1Y
20.3%
Xencor
Market Cap: US$592.9m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$8.33
7D
-26.0%
1Y
-62.9%
KalVista Pharmaceuticals
Market Cap: US$591.6m
A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
KALV
US$11.90
7D
-12.2%
1Y
-1.5%
Avanos Medical
Market Cap: US$585.0m
A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
AVNS
US$12.65
7D
2.9%
1Y
-35.4%
Iovance Biotherapeutics
Market Cap: US$584.4m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
IOVA
US$1.75
7D
-50.0%
1Y
-84.0%
Botanix Pharmaceuticals
Market Cap: AU$908.6m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.47
7D
2.2%
1Y
69.1%
Bicycle Therapeutics
Market Cap: US$577.6m
A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.
BCYC
US$8.34
7D
-7.9%
1Y
-63.0%
CeriBell
Market Cap: US$577.2m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$15.97
7D
-2.1%
1Y
n/a
AnaptysBio
Market Cap: US$575.6m
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
ANAB
US$19.59
7D
-7.6%
1Y
-16.3%
Tian'an Technology Group
Market Cap: US$569.0m
Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.
TANA.F
US$12.50
7D
4.2%
1Y
n/a
Fortrea Holdings
Market Cap: US$556.8m
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE
US$6.15
7D
-1.8%
1Y
-81.4%
Keros Therapeutics
Market Cap: US$554.4m
A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.
KROS
US$13.65
7D
-6.8%
1Y
-74.8%
Butterfly Network
Market Cap: US$551.4m
Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY
US$2.23
7D
-4.3%
1Y
118.6%
Advanced Medical Solutions Group
Market Cap: UK£413.7m
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.
AMS
UK£1.93
7D
-5.7%
1Y
-7.1%
Cogent Biosciences
Market Cap: US$548.0m
A biotechnology company, focuses on developing precision therapies for genetically defined diseases.
COGT
US$4.81
7D
-18.1%
1Y
-36.4%
OrthoPediatrics
Market Cap: US$545.9m
A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
KIDS
US$22.04
7D
3.0%
1Y
-29.1%
Regulus Therapeutics
Market Cap: US$544.9m
A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.
RGLS
US$7.87
7D
0.3%
1Y
256.1%
Sionna Therapeutics
Market Cap: US$543.6m
A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
SION
US$12.32
7D
-9.3%
1Y
n/a
Healius
Market Cap: AU$838.7m
Provides specialty diagnostic services to consumer and practitioners in Australia.
HLS
AU$1.16
7D
-23.3%
1Y
-7.6%
Owens & Minor
Market Cap: US$537.1m
Operates as a healthcare solutions company worldwide.
OMI
US$7.01
7D
-6.7%
1Y
-62.4%